Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Valvular Heart Disease

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 48 articles:
HTML format



Single Articles


    May 2022
  1. GAMMIE JS, Hung J, Ailawadi G
    Tricuspid Repair in Patients with Degenerative Mitral Regurgitation. Reply.
    N Engl J Med. 2022;386:1862-1863.
    PubMed    


  2. TOMSIC A, Palmen M, Klautz RJM
    Tricuspid Repair in Patients with Degenerative Mitral Regurgitation.
    N Engl J Med. 2022;386:1862.
    PubMed    


  3. GUPTA R, Gerges F, Gupta N
    Tricuspid Repair in Patients with Degenerative Mitral Regurgitation.
    N Engl J Med. 2022;386:1861-1862.
    PubMed    


  4. BELLUMKONDA L
    Tricuspid Repair in Patients with Degenerative Mitral Regurgitation.
    N Engl J Med. 2022;386:1861.
    PubMed    


    April 2022
  5. MATZA MA, Rincon SP, Yucel E, Jorge AM, et al
    Case 12-2022: A 41-Year-Old Woman with Transient Ischemic Attack and Mitral Valve Masses.
    N Engl J Med. 2022;386:1560-1570.
    PubMed    


  6. AIKAWA E, Hutcheson JD
    The Developmental Origin of Calcific Aortic Stenosis.
    N Engl J Med. 2022;386:1372-1374.
    PubMed    


    November 2021
  7. CHIKWE J, Gaudino M
    The Price of Freedom from Tricuspid Regurgitation.
    N Engl J Med. 2021 Nov 13. doi: 10.1056/NEJMe2116776.
    PubMed    


  8. GAMMIE JS, Chu MWA, Falk V, Overbey JR, et al
    Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation.
    N Engl J Med. 2021 Nov 13. doi: 10.1056/NEJMoa2115961.
    PubMed     Abstract available


    July 2021
  9. VARELA DL, Jones TL
    Perivalvular Abscess Causing Coronary-Artery Compression.
    N Engl J Med. 2021;385:e3.
    PubMed    


    March 2021
  10. BERWANGER O, Guimaraes HP, Lopes RD
    Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve. Reply.
    N Engl J Med. 2021;384:975-976.
    PubMed    


  11. DURAES AR, Bitar YSL
    Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
    N Engl J Med. 2021;384:975.
    PubMed    


  12. ALGHAMRY A, Lee JC
    Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
    N Engl J Med. 2021;384:974-975.
    PubMed    


  13. LOTLIKAR A, Anwar S
    Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
    N Engl J Med. 2021;384:974.
    PubMed    


  14. VERMA A, Dhingra N, Yanagawa B
    Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
    N Engl J Med. 2021;384:973-974.
    PubMed    


    January 2021
  15. BROUWER J, Nijenhuis VJ, Ten Berg JM
    Single or Dual Antiplatelet Treatment after TAVI. Reply.
    N Engl J Med. 2021;384:90-91.
    PubMed    


  16. FAHRNI G, Jeger R, Mueller C
    Single or Dual Antiplatelet Treatment after TAVI.
    N Engl J Med. 2021;384:90.
    PubMed    


  17. EIKELBOOM R, Belley-Cote EP, Whitlock RP
    Single or Dual Antiplatelet Treatment after TAVI.
    N Engl J Med. 2021;384:90.
    PubMed    


  18. ANWAR S, Spence E, Zawadka M
    Single or Dual Antiplatelet Treatment after TAVI.
    N Engl J Med. 2021;384:89-90.
    PubMed    


    November 2020
  19. GUIMARAES HP, Lopes RD, de Barros E Silva PGM, Liporace IL, et al
    Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
    N Engl J Med. 2020 Nov 14. doi: 10.1056/NEJMoa2029603.
    PubMed     Abstract available


    October 2020
  20. CORTAZAR FB, Rhee EP, Gupta S, Sakhuja R, et al
    Case 34-2020: A 74-Year-Old Man with Chronic Kidney Disease.
    N Engl J Med. 2020;383:1768-1778.
    PubMed    


  21. O'GARA PT, Mack MJ
    Secondary Mitral Regurgitation.
    N Engl J Med. 2020;383:1458-1467.
    PubMed    


    August 2020
  22. BROUWER J, Nijenhuis VJ, Delewi R, Hermanides RS, et al
    Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation.
    N Engl J Med. 2020 Aug 30. doi: 10.1056/NEJMoa2017815.
    PubMed     Abstract available


  23. VAN BELLE E, Labreuche J, Vincent F
    Five-Year Outcomes with Transcatheter Aortic-Valve Replacement. Reply.
    N Engl J Med. 2020;383:596.
    PubMed    


  24. MAKKAR RR, Mack MJ, Leon MB
    Five-Year Outcomes with Transcatheter Aortic-Valve Replacement. Reply.
    N Engl J Med. 2020;383:595-596.
    PubMed    


  25. KHOKHAR AA, Giannini F, Colombo A
    Five-Year Outcomes with Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2020;383:594-595.
    PubMed    


  26. BARILI F, Freemantle N, Parolari A
    Five-Year Outcomes with Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2020;383:594.
    PubMed    


    July 2020
  27. DANGAS GD, De Backer O, Windecker S
    A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement. Reply.
    N Engl J Med. 2020;383:e8.
    PubMed    


  28. ALGHAMRY A, Murdoch DJ
    A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2020;383:e8.
    PubMed    


  29. STOJKOVIC S, Sulzgruber P, Niessner A
    A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2020;383:e8.
    PubMed    


  30. YAHAGI K, Sato Y, Virmani R
    A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2020;383:e8.
    PubMed    


  31. MARTIN AC, Smadja DM, Karam N
    A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2020;383:e8.
    PubMed    


  32. KANG DH, Park SW
    Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis. Reply.
    N Engl J Med. 2020;383:92-93.
    PubMed    


  33. SIDEBOTHAM D, Morrow CD, Drake DH
    Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis.
    N Engl J Med. 2020;383:92.
    PubMed    


  34. GARRY JD, Goldman M, Kohlwes J
    Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis.
    N Engl J Med. 2020;383:91-92.
    PubMed    


    April 2020
  35. FEIT F
    How Un-POPular Is Bleeding in Patients with TAVI?
    N Engl J Med. 2020;382:1761-1763.
    PubMed    


    March 2020
  36. NIJENHUIS VJ, Brouwer J, Delewi R, Hermanides RS, et al
    Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation.
    N Engl J Med. 2020 Mar 29. doi: 10.1056/NEJMoa1915152.
    PubMed     Abstract available


    February 2020
  37. MAKKAR RR, Thourani VH, Mack MJ, Kodali SK, et al
    Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement.
    N Engl J Med. 2020;382.
    PubMed     Abstract available


    January 2020
  38. KANG DH, Park SJ, Lee SA, Lee S, et al
    Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis.
    N Engl J Med. 2020;382.
    PubMed     Abstract available


  39. LANCELLOTTI P, Vannan MA
    Timing of Intervention in Aortic Stenosis.
    N Engl J Med. 2020;382.
    PubMed    


  40. NISHIMURA RA, Holmes DR Jr
    Treatment after TAVR - Discordance and Clinical Implications.
    N Engl J Med. 2020;382:193-194.
    PubMed    


    November 2019
  41. FAROOQUI FA, Deepti S
    Myxomatous Mitral-Valve Prolapse.
    N Engl J Med. 2019;381:e37.
    PubMed    


  42. DE BACKER O, Dangas GD, Jilaihawi H, Leipsic JA, et al
    Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2019 Nov 16. doi: 10.1056/NEJMoa1911426.
    PubMed     Abstract available


  43. DANGAS GD, Tijssen JGP, Wohrle J, Sondergaard L, et al
    A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2019 Nov 16. doi: 10.1056/NEJMoa1911425.
    PubMed     Abstract available


    October 2019
  44. VEMULAPALLI S, Carroll JD, Mack MJ
    Volume and Outcomes for Transcatheter Aortic-Valve Replacement. Reply.
    N Engl J Med. 2019;381:1394-1395.
    PubMed    


  45. SHARMA A
    Volume and Outcomes for Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2019;381:1394.
    PubMed    


  46. GOLDBERG SL, Gray RM, Horne A Jr
    Volume and Outcomes for Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2019;381:1393-1394.
    PubMed    


  47. NOBLE S, Frei A
    Volume and Outcomes for Transcatheter Aortic-Valve Replacement.
    N Engl J Med. 2019;381:1393.
    PubMed    


  48. ACEITUNO J, Ramirez P
    Landolfi's Sign.
    N Engl J Med. 2019;381:e29.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Valvular Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: